Hengrui intends to share these Phase 2 clinical trial data evaluating the 8mg dose of HRS9531 at an upcoming scientific conference
For example, between 29 and 34% of participants experienced nausea with orforglipron compared with 25 to 29% in Zepbound trials
Over the past decade, studies have shown GLP-1 receptor agonists like semaglutide (Ozempic or Wegovy) reduce food seeking, but also alcohol intake, cocaine reward, nicotine self-administration, and relapse-like behavior spanning multiple drug classes
GLP-1 Support, Done Safely Whether youre already on GLP-1s or considering them, we protect your muscle, metabolism, and mindset with labs, protein planning, and movement coaching
Inflammation markers when clinically useful
doi:10.1017/S0007114511003163